Literature DB >> 8376093

Quality of life and well-being of headache patients: measurement by the medical outcomes study instrument.

G D Solomon1, F G Skobieranda, L A Gragg.   

Abstract

OBJECTIVE: To assess the reliability and validity of the Medical Outcomes Study (MOS) Short Form Health Survey as an indicator for quality of life in patients with chronic headaches.
DESIGN: Patient interview survey.
SETTING: A headache clinic within a multi-specialty group practice. PATIENTS: 208 consecutive patients seeking evaluation of headache at the above site. MEASUREMENTS: All six health components of the MOS Short Form Health Survey were included in the study. MAIN
RESULTS: The MOS Short Form Health Survey was both reliable and valid in the group of patients with headache. Patients with headache had significantly worse physical, social, and role functioning, and worse mental health than did patients with chronic diseases (P < 0.0001). The functioning associated with chronic headaches was worse than that associated with major chronic medical conditions such as arthritis and diabetes, and was comparable to the level of functioning associated with recent myocardial infarction or congestive heart failure.
CONCLUSIONS: The MOS survey is a reliable measure of quality of life for patients with chronic headaches. Chronic headache disorders cause significantly more morbidity and impairment of function than has previously been appreciated.

Entities:  

Mesh:

Year:  1993        PMID: 8376093     DOI: 10.1111/j.1526-4610.1993.hed3307351.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  21 in total

Review 1.  Evaluation of quality of life for diverse patient populations.

Authors:  K R Yabroff; B P Linas; K Schulman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 2.  Quality-of-life assessment in patients with headache.

Authors:  G D Solomon
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

Review 3.  Sumatriptan. A pharmacoeconomic review of its use in migraine.

Authors:  A J Coukell; H M Lamb
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

4.  Quality of life bibliography and indexes: 1993 update.

Authors:  R A Berzon; G P Simeon; R L Simpson; M A Donnelly; H H Tilson
Journal:  Qual Life Res       Date:  1995-02       Impact factor: 4.147

5.  Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma.

Authors:  R K Parrish
Journal:  Trans Am Ophthalmol Soc       Date:  1996

6.  MSQ: Migraine-Specific Quality-of-Life Questionnaire. Further investigation of the factor structure.

Authors:  P Jhingran; S M Davis; L M LaVange; D W Miller; R W Helms
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

7.  Factors associated with migraine-related quality of life and disability in adolescents: a preliminary investigation.

Authors:  Gregg A Tkachuk; Constance K Cottrell; Jessica S Gibson; Francis J O'Donnell; Kenneth A Holroyd
Journal:  Headache       Date:  2003-10       Impact factor: 5.887

8.  Dose response and efficacy of spinal manipulation for chronic cervicogenic headache: a pilot randomized controlled trial.

Authors:  Mitchell Haas; Adele Spegman; David Peterson; Mikel Aickin; Darcy Vavrek
Journal:  Spine J       Date:  2010-02       Impact factor: 4.166

9.  Diagnosing headache in primary care: a qualitative study of GPs' approaches.

Authors:  Stefan Bösner; Simone Hartel; Judith Diederich; Erika Baum
Journal:  Br J Gen Pract       Date:  2014-09       Impact factor: 5.386

10.  GPs' classification of headache: is primary headache underdiagnosed?

Authors:  David Kernick; Sally Stapley; William Hamilton
Journal:  Br J Gen Pract       Date:  2008-02       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.